Tylenol and Alcohol Use May Double Risk of Kidney Problems: Study

In recent years, health officials have focused a lot of attention on raising awareness about the risk of liver damage from side effects of Tylenol and its active ingredient, acetaminophen, but a new study now indicates that when alcohol is combined with the popular pain reliever, users may also face an increased risk of kidney injury.  

According to the findings of a study presented at the 141st annual meeting of the American Public Health Association in Boston, combining Tylenol and alcohol may double the risk of kidney problems.

The preliminary findings were conducted by researchers from Parker University in Dallas, Texas, but the study has not yet been peer reviewed or published.

Tylenol Autism Lawsuit

Does your child have Austism from Tylenol Exposure?

Side effects of Tylenol may cause autism and ADHD among children exposed during pregnancy. Find out if your family may be eligible for a Tylenol autism or ADHD settlement.

Learn More See If You Qualify For Compensation

Researchers looked at data on more than 10,000 participants in the 2003-2004 U.S. National Health and Nutrition Examination Survey, which asked about health problems, the use of medication and the use of alcohol. The findings suggest that individuals who took Tylenol or other acetaminophen products in combination with a small to moderate amount of alcohol saw a 123% increase in the risk of kidney disease. However, neither acetaminophen or alcohol by themselves appeared to have any association with kidney problems.

The study’s findings indicated only an association, but did not establish a cause-and-effect relationship. However, researchers said that alcohol is known to interfere with the gene that controls how your body processes acetaminophen, which could explain the increased kidney risk.

Tylenol and other acetaminophen-based drugs carry a label warning not to take them with alcohol.

Johnson & Johnson currently faces several hundred Tylenol lawsuits brought on behalf of individuals who suffered liver failure or other liver injury after using the pain medication. The complaints allege that the drug maker has known about the Tylenol liver risks for decades, yet withheld important information from consumers and the medical community.

In 2011, the recommended daily dose for Tylenol was reduced from 4,000 mg per day to 3,000mg, due to the risk of liver damage. However, the drug maker has faced substantial criticism for selling Extra Strength Tylenol, which contains 500mg in each tablet and poses a serious risk of liver failure if consumers take more than two tablets every six hours.

Due to the widespread use of Tylenol and other similar cold products, federal health officials have been focusing in recent years on raising awareness about the risk of overdosing on acetaminophen, including the risk of taking multiple medications that contain the pain killer.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S.
Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S. (Posted today)

A recently filed Depo-Provera lawsuit questions why Pfizer updated the drug label in Europe, to warn about the risk of meningioma brain tumors, but failed to provide the same Depo-Provera warnings to U.S. consumers and doctors.

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week
Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted 2 days ago)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.